Skip to main content
. 2020 Jan 28;4:CCI.19.00097. doi: 10.1200/CCI.19.00097

FIG 4.

FIG 4.

Sankey flow diagram focusing on the flow of evidence between drug-gene and gene connections for a putative patient with estrogen receptor–positive breast cancer and FGFR1 overexpression, showing category 3 recommendations, namely, targets downstream of FGFR1. Therapies can be clicked to obtain a panel with PubChem information.